Lidgren M, Wilking N, Jönsson B, Rehnberg C. Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer. AO [Internet]. 2008 Jan. 1 [cited 2024 Nov. 9];47(6):1018-2. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25894